AYUSH Ministry Issues Revised Advisory To Fight Against COVID-19
New Delhi: As India witnesses a steep surge in COVID-19 cases, the Ministry of AYUSH (MoA) on Wednesday issued revised guidelines and advisory to fight against coronavirus infection.
In the advisory, MoA said, "People should use Ayuraksha kit which has chyawanprash, 6pgm once a day, Ayush Kwath 75ml once a day, Samshamani Vati 500 mg twice a day, Anutaila one to two drops nasal application in each nostril once a day."
Also Read:Union Health Ministry updates home isolation rules: Quarantine period cut to 7 days
The ministry also recommends a few medicines against coronavirus infection. "AYUSH-64 (2 tablets of 500 mg twice in a day in asymptomatic COVID-19, 2 tablets of 500 mg thrice a day in mild to moderate COVID), Kabasura Kudineer (5 gm twice in a day)," the ministry said.
For COVID-19 Prophylaxis, it recommends Arsenicum album 30C, Khareema Marwareed medicines.
This came after the Union Health ministry addressed a press conference on the COVID-19 management in the national capital today.
Also Read:Now Ayurvedic practitioners can issue medical certificate for driving license
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!